Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial

Arman Qamar, David A. Morrow, Mark A. Creager, Benjamin M. Scirica, Jeffrey W. Olin, Joshua A. Beckman, Sabina A. Murphy, Marc P. Bonaca

Research output: Contribution to journal › Article › peer-review